An RNA Aptamer Inhibits a Mutation-Induced Inactivating Misfolding of a Serpin

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Jeppe B Madsen
  • ,
  • Lisbeth M Andersen
  • ,
  • Daniel M Dupont
  • Morten B Trelle, University of Southern Denmark
  • ,
  • Jesper S Johansen
  • ,
  • Jan K Jensen
  • Thomas J D Jørgensen, University of Southern Denmark
  • ,
  • Peter A Andreasen

Most serpins are fast and specific inhibitors of extracellular serine proteases controlling biological processes such as blood coagulation, fibrinolysis, tissue remodeling, and inflammation. The inhibitory activity of serpins is based on a conserved metastable structure and their conversion to a more stable state during reaction with the target protease. However, the metastable state also makes serpins vulnerable to mutations, resulting in disease caused by inactive and misfolded monomeric or polymeric forms ("serpinopathy"). Misfolding can occur either intracellularly (type-I serpinopathies) or extracellularly (type-II serpinopathies). We have isolated a 2'-fluoropyrimidine-modified RNA aptamer, which inhibits a mutation-induced inactivating misfolding of the serpin α1-antichymotrypsin. It is the first agent able to stabilize a type-II mutation of a serpin without interfering with the inhibitory mechanism, thereby presenting a solution for the long-standing challenge of preventing pathogenic misfolding without compromising the inhibitory function.

Original languageEnglish
JournalCell Chemical Biology
Pages (from-to)700–708
Number of pages9
Publication statusPublished - 1 Jun 2016

See relations at Aarhus University Citationformats

ID: 100553650